In the invasive front, we found a higher density of CD3 and CD4 cells in less advanced cancers, i.e., in T1-T2 CRC and in lower TNM stage (TNM-I vs TNM-II and TNM-I vs TNM-III). The gene discussed is CD4; the disease is cancer.